BIOSPAIN 2026: Full Schedule

11:30 CEST

Tuesday September 29, 2026 11:30 - 12:15 CEST

Meet innovative startups that are seeking funding to address some of the key challenges of our society. From global warming to the challenge of feeding more than 8 billion people or the need to manage waste and byproducts, biotechnology is offering creative solutions and alternatives.

Start-ups will have the opportunity to present their business plans to a panel of investors. Attendees will be invited to vote for the best start up pitch presentation. The winner will get a free registration to BIOSPAIN 2026.

Presenting companies:

Bioceanics – Clara Bartra, CEO
BioPredX – Helena García Cebollada, CEO
Calfix – Pablo Montequín, CEO
Genbioma – Josune Ayo, CEO
Heuristik – Antxon Caballero, CEO
NUCAPS – Mariano Oto, CEO

Speakers

Helena García Cebollada

CEO, BioPredX

Helena García Cebollada (she/her) is the CEO of BioPredX. After getting her PhD in Bioinformatics in 2022, she continued developing predictive software for proteins and genetic variants in her postdoctoral work. This was the starting seed for BioPredX, which she founded in 2026 in... Read More →

Pablo Montequín

CEO & Co-founder, Calfix

Entrepreneur and legal professional with a Master’s in Intellectual Property & Technology, bringing a proven track record in driving industrial, biotech, and tech projects across Latam, Ireland, and Israel. Heads strategic growth and fundraising initiatives, bridging the gap between... Read More →

Josune Ayo

CEO, Genbioma

Josune Ayo, Ph.D., CEO and co-founder of Genbioma. Ph.D. in Food Technology (UCM) with over 25 years of experience in food innovation. Research background includes 40 publications and four patents, focused on developing foods with nutritional and health benefits. Active member of Food and... Read More →

Antxon Caballero

CEO, Heuristik

Antxon is a serial entrepreneur with a successful exit. Antxon studied administration and finances with a masters in Big Data, he has international experience in sales and project management, he co founded Heuristik 6 years ago when a nurse made a wrong identification error to his... Read More →

Mariano Oto

CEO, Nucaps

Mariano Oto. Bachelor’s Degree in Economics and Business Sciences, with postgraduate studies in international trade. Entrepreneur and senior executive with more than 20 years of experience in business leadership, commercial strategy, and innovation management. Since 2017, CEO of... Read More →

Tuesday September 29, 2026 11:30 - 12:15 CEST
3 Nicolás Achúcarro room

Startup pitch presentations

Audience English language
Track Bio economy

12:15 CEST

Startup Pitch Presentations: Oncology

Tuesday September 29, 2026 12:15 - 13:15 CEST

4 Raúl Martín room

Companies seeking funding to develop treatments in neurology and oncology will present their companies and pitch their business opportunity.

Attendees will be invited to vote for the best start up pitch presentation. The winner will get a free registration to BIOSPAIN 2027.

Ability Pharmaceuticals, SA – Carles Domènech, CEO
Innoup Farma Kinsy, S.l. – Elisa Longás, Chief Business Officer
Labsinlove S.L. - Cristina Aguilera, CEO
Lifesome Therapeutics, S.L. – Ana Bouchet, CEO
MIMO BIOSCIENCES – Jessika Valero Gonzalez,. Business Development Director
Nuage Therapeutics – Andri Leonidou, Head Of Bi And Corporate Affairs
Oncomatryx Biopharma SA – Teresa Rodriguez-Carmona Garcia, Business Development Associate
Peptomyc, S.l. – Jesús Martín García, CEO
Trimerbody Pharma – Marta Compte Grau, R&D Director

Speakers

Carles Domènech

CEO, Ability Pharma, S.A.

Carles Domènech, PhD, is Executive Chairman, CEO and co-founder of AbilityPharma, with 30+ years of international experience in biotech, pharma business development, licensing and venture capital. He holds a Biology degree and PhD from Universitat Autònoma de Barcelona, plus business... Read More →

Elisa Longás

Chief Business Officer, Innoup Pharma

Elisa Longás is Chief Business Officer at InnoUp Farma, where she leads corporate strategy, business development and global partnering initiatives. She combines scientific and biotech & pharmaceutical business expertise to drive strategic growth opportunities and international collaborations... Read More →

Cristina Aguilera

CEO, Labsinlove

Cristina Aguilera Xiol, PhD MBM, is CEO of Labsinlove and has an international background in biotechnology, translational medicine and innovation management. She started her career in academia as a researcher and later worked internationally across both academia and industry, including... Read More →

Ana Bouchet

CEO, Lifesome Therapeutics, S.L.

Ana Bouchet is the Co-founder and CEO of Lifesome Therapeutics. She holds a degree in Biotechnology and a PhD in Lipid Biophysics. Her research interests include nanotechnology, molecular delivery, and biophysics applied to biomaterials. In 2022, she spearheaded the company’s growth... Read More →

Jessika Valero Gonzalez

Business Director, Mimo Biosciences

Jessika Valero González, PhD, leads Business Development and Strategy at MIMO Biosciences, where she drives growth, strategic partnerships, and market expansion. With extensive experience in biotechnology innovation and commercialization, she focuses on connecting breakthrough science... Read More →

Andri Leonidou

Head Of Bi And Corporate Affairs, Nuage Therapeutics

Andri Leonidou is Head of Business Intelligence and Corporate Affairs at Nuage Therapeutics, responsible for competitive intelligence, partnership assessments, and strategic insights to support the company's pipeline and business development activities. She holds a PhD in breast cancer... Read More →

Teresa Rodríguez-Carmona García

Business Development Associate, Oncomatryx Biopharma SA

Teresa is a business development associate at Oncomatryx Biopharma S.A. since October 2025. She supports BD activities by contributing to strategic partnerships, market analysis and stakeholder engagement for preclincial and clinical programs. Teresa holds a Bsc (Honours) in Biomedical... Read More →

Jesús Martin Garcia

CEO, Peptomyc, S.L.

Jesús Martín García is CEO of Peptomyc, with over two decades of leadership in drug development, biotech strategy and corporate finance. He has held CEO and Board roles, leading clinical-stage programs, partnering transactions and capital raises from Series A through IPO. He holds... Read More →

Marta Compte Grau

R&D Director, Trimerbody Pharma

Marta Compte Grau MD, PhD Immunologist and biotech executive with more than 15 years of experience in immuno-oncology, antibody engineering and translational development of biologics. Currently leading scientific, operational and strategic activities at Trimerbody Pharma, advancing... Read More →

Tuesday September 29, 2026 12:15 - 13:15 CEST
4 Raúl Martín room

Startup pitch presentations

Audience English language
Track Finance & investment

15:15 CEST

Startup Pitch Presentations: Devices & Diagnostics

Tuesday September 29, 2026 15:15 - 15:45 CEST

4 Raúl Martín room

Build high-impact investor pitches that translate medical-device and in vitro diagnostics innovation into clear financial potential and patient-outcome narratives investors can’t ignore.

Attendees will be invited to vote for the best start up pitch presentation. The winner will get a free registration to BIOSPAIN 2027.

Debios Diagnostics — Joan Grasas, Ceo
Manina Medtech — Mónica, Rodríguez de la Vega Otazo, CEO
Opportunity Health — Germán Alejandro Sánchez Martín, CEO
Optec4Life — Francesc Paris Huguet, CEO

Speakers

Joan Grasas

CEO, Debios Diagnostics

Joan Grasas is a catalyser of innovation and entrepreneurship. His background includes experience at the Institut Català de la Salut, the largest healthcare provider in Catalonia, and long-standing involvement with EIT Health. He has co-founded and led healthtech and IVD projects... Read More →

Mónica de la Vega

CEO, Manina Medtech

Monica is the co-founder and CEO of Manina Medtech. She has a Ph.D. in Biochemistry, 20+ years of research in life sciences, and a master's degree in Biodesign, Innovation, and Healthcare Entrepreneurship. Monica previously worked with RehaBeats, an online cardiac rehabilitation startup... Read More →

Nicolás López de Aguileta Castaño

CTO, Oppotunitiy Health

Biomedical Engineer and CTO of Opportunity Health, a medtech company developing connected respiratory care solutions. Nicolás specializes in medical device development, regulatory strategy and healthcare innovation, with previous experience at the Navarra Health Service, BCN3D and... Read More →

Francesc Paris Huguet

CEO, Optec4Life

Tuesday September 29, 2026 15:15 - 15:45 CEST
4 Raúl Martín room

Startup pitch presentations

Audience English language
Track Finance & investment

10:15 CEST

Startup pitch presentations: Early stage companies

Wednesday September 30, 2026 10:15 - 10:45 CEST

4 Raúl Martín room

Meet early stage companiesseeking seed/series A funding

Attendees will be invited to vote for the best start up pitch presentation. The winner will get a free registration to BIOSPAIN 2027.

Backpacked-Antibody platform – Izaskun Morillo, Postdoctoral Researcher
Exitium Therapeutics – Angélica Figueroa Conde-Valvís, CSO
Korum Diagnostics – Carla Ferrero Ruedas, CEO
Lumina – Guillem Loren, CEO
Platelet Biotechnologies S.l. – Andrea Acebes Huerta, CEO & Cofounder

Speakers

Izaskun Morillo

Postdoctoral Researcher, Backpacked-Antibody platform (EHU)

Izaskun is a postdoctoral researcher in the Antibody Engineering and Membrane Biophysics in Disease group at Biofisika Institute. Since 2021, my research has focused on improving monoclonal antibodies for cancer therapy by enhancing their cargo capacity. This work led to the development... Read More →

Angélica Figueroa Conde-Valvís

CSO, Exitium Therapeutics

Dra. Angélica Figueroa is a cancer researcher and innovation leader at INIBIC with more than 20 years of experience in molecular oncology, including work at international institutions such as the Medical Research Council-University College London, the National Institute on Aging... Read More →

Carla Ferrero Ruedas

CEO, Korum Diagnostics

CEO of Korum Diagnostics and PhD in Biotechnology specialized in infectious diseases and antimicrobial resistance (AMR). Background in translational research and early-stage technology transfer, developing rapid diagnostic solutions for clinical use. Focused on transforming scientific... Read More →

Guillem Loren

CEO, Lumina

Driving the development of novel light‑activated oncology therapies. PhD in Organic Chemistry and a Master's in Business Management in Biomedicine. My previous experience includes innovation management at a biotech spin-off and the design and synthesis of anticancer PROTACs.

Andrea Acebes Huerta

CEO & Cofounder, Platelet Biotechnologies S.l.

Dr. Andrea Acebes Huerta is CEO and Co-founder of Platelet Biotechnologies and a scientist specialized in regenerative medicine and platelet-based therapies. She holds a PhD in Biochemistry from the University of Oviedo, awarded with International Mention and EMBO Fellowship recognition... Read More →

Wednesday September 30, 2026 10:15 - 10:45 CEST
4 Raúl Martín room

Startup pitch presentations

Audience English language
Track Finance & investment

11:30 CEST

Startup Pitch Presentations ATMP

Wednesday September 30, 2026 11:30 - 12:15 CEST

4 Raúl Martín room

Meet innovative companies developing Advanced Therapy Medicinal Products, which are innovative drugs for human used based on genes, cells or tissue engineering.

Start-ups will have the opportunity to present their business plans to a panel of investors. Attendees will be invited to vote for the best start up pitch presentation. The winner will get a free registration to BIOSPAIN 2026.

Presenting companies:

Amets Biotechnology – Laia Trigueros Motos, CEO
Golden Gate Biotech - Jascha Blobel, CEO
Miramoon Pharma – Amalia Capilla, CEO
Nocturna Therapeutics – Miriam Corredor, CEO
Peaches S.l. – Francesca Sarno, CSO
Popcorn Therapeutics – Iker Ausejo Mauleon,COO
Tetraneuron SL – Ángel Lucio Pereira, CEO

Speakers

Laia Trigueros Motos

CEO, Amets Biotechnology

Solid track record in biomedical research and strategic leadership, resulting in impactful scientific solutions. Training in business management with the mission of guiding the clinical translation and international growth of Amets Biotechnology.

Jascha Blobel

Founder & Chief Executive Officer, Golden Gait Biotech

Jascha Blobel is working since over 15 years in the development of biotech companies. Has has been involved in 3 out-licensing deals. As co-founder and CEO of Molomics Biotech, the company was sold to San Fransisco based VeriSIM Life in 2022. Jascha studied chemistry at the Ludwig-Maximilians... Read More →

Amalia Capilla

CEO, Miramoon Pharma

Dr. Amalia Capilla is CEO of Miramoon Pharma and a biotech executive with 20+ years of experience in regenerative medicine, gene and cell therapy, and translational research. She holds a PhD in Molecular Biology from the University of Valencia and completed postdoctoral training at... Read More →

Miriam Corredor Sánchez

CEO, Nocturna Therapeutics

Miriam Corredor is CEO of NoctuRNA Therapeutics, a biotech company developing novel circular RNA therapeutics for neurodegenerative, neuromuscular and infectious diseases. She holds a PhD in Medicinal Chemistry in neurodegenerative diseases and a Master’s in Business Innovation... Read More →

Francesca Sarno

CSO, Peaches S.L.

PhD in Biology with 15+ years of experience in translational oncology and advanced therapy development. Formerly involved in CNIO and hospital-based research, with 20+ scientific publications and experience coordinating European R&D projects. As Scientific Director at Peaches Biotech... Read More →

Iker Ausejo Mauleon

COO, Popcorn Therapeutics

Dr. Iker Ausejo Mauleon obtained his Ph.D. in applied medicine and biomedicine from the University of Navarra in 2023, complemented by international experience at the MD Anderson Cancer Center in Houston. Recognized as an emerging talent under 35 in Navarra, he has received 8 prestigious... Read More →

Ángel Lucio Pereira

CEO, Tetraneuron S.L.

Angel Lucio is the CEO of Tetraneuron, a Spanish biotech company, advancing gene therapy solutions for Alzheimer’s disease and other neurodegenerative diseases. After several years supporting the company as an advisor and board member, Angel now leads its next phase of growth, as... Read More →

Wednesday September 30, 2026 11:30 - 12:15 CEST
4 Raúl Martín room

Startup pitch presentations

Audience English language
Track Finance & investment

15:15 CEST

Startup Pitch Presentations. Drug Development & Delivery

Wednesday September 30, 2026 15:15 - 16:30 CEST

4 Raúl Martín room

Each company will be given a six-minute spotlight to unveil investment opportunities in drug development and delivery—six minutes to ignite interest and sketch the future of medicine.

Attendees will be invited to vote for the best start up pitch presentation. The winner will get a free registration to BIOSPAIN 2027.

Vaxdyn – Juan José Infante Viñolo, CEO
FatrixGel – Pablo Sánchez-Rey Chiapasco, CEO & Founder
Flavii Therapeutics – Ariadna Boloix Amenós & Ainia Bellver , CEO & CSO & Co-founders
Gate2brain – Mertixell Teixidó Turà, CEO & CSO
i+Med S.coop – Andrea Zapater Matute, R&D Business Developer
Molefy Pharma - Tania Ortuño, Head of Operations
Nanogrow Biotech – Nicolás Galmarini Galmarini, CEO & Co-founder
Nostrum Biodiscovery –Marie-Eve Beaulieu, General Manager
Olavide Neuron STX S.L. (ONESTX) – Ángel Cebolla Ramírez, CEO
Ploid AI Biotech - Adolfo Gastalver, Co-Founder & CEO
Resistia – Ignacio Massone, CEO & Co-founder

Speakers

Juan José Infante Viñolo

CEO, Vaxdyn

Dr. Infante leads Vaxdyn and its international collaboration network, advancing vaccines against antibiotic-resistant bacteria. As co-inventor of the company's core technology, he has secured funding from CARB-X, the European Commission and specialist investors. His background combines... Read More →

Pablo Sanchez-rey

CEO & Founder, FatrixGel

Biologist and biotechnologist with a PhD in Biological Sciences and over 10 years of experience in the startup ecosystem. Former COO of a Fermentation Biotech, leading operations, strategic execution, and stakeholder relations. Currently CEO and founder of Fatrix Biotech, a biomaterial... Read More →

Ariadna Boloix Amenós

CEO & Co-founder, Flavii Therapeutics

Dr. Ariadna Boloix Amenós is CEO & Co-founder of Flavii Therapeutics S.L., leading corporate strategy and business development. She holds a PhD in Biochemistry and Biomedicine (UAB) and a Pharmacy degree (UB). Her research at the Vall d’Hebron Research Institute and Institute of Materials Science of Barcel... Read More →

Meritxell Teixidó Turà

Ceo & Cso, Gate2brain

Meritxell Teixidó holds a PhD in Organic Chemistry from the University of Barcelona and an eMBA from UOC. She spent more than 15 years at IRB Barcelona leading research on peptides capable of crossing biological barriers, co-supervising 10 PhDs, publishing over 50 scientific articles... Read More →

Andrea Zapater Matute

R&D Business Developer, i+Med S.coop

Andrea Zapater, PhD, is an R&D Business Development Manager at i+Med, focused on advanced biomaterials and drug delivery technologies for innovative therapeutic applications. She holds a PhD in Personalized Medicine and has experience in biotechnology, translational research, and... Read More →

Tania Ortuño

Head of Operations, Molefy Pharma SL

Tania Ortuño is a biologist and doctor in Neuroscience with extensive experience combining scientific R&D with business development skills in innovation-driven environments. Her career spans neuroscience research and biotech operations, giving her a multidisciplinary profile at the... Read More →

Nicolás Galmarini

CEO & Co-founder, Nanogrow Biotech

Economist and MBA with over 20 years in the pharmaceutical industry and a proven track record in establishing businesses across Latin America. Holds a BA in Economics from UdelaR and an MBA from Universidad Austral (Argentina). His extensive experience and entrepreneurial mindset... Read More →

Marie-eve Beaulieu

General Manager, Nostrum Biodiscovery

Marie-Eve Beaulieu, PhD is General Manager of Nostrum Biodiscovery, a Barcelona- and Boston-based computational drug discovery technology company developing physics-based AI platforms for therapeutic design. She brings over 15 years of experience spanning drug discovery and executive leadership in biotech. Pr... Read More →

Angel Cebolla Ramírez

CEO, Olavide Neuron STX S.L. (ONESTX)

Dr. Ángel Cebolla is a scientist and serial bioentrepreneur with more than 25 years of experience translating academic research into profitable biotech solutions. After founding Biomedal and leading its world-class rapid food diagnostics division to a successful exit with the US... Read More →

Adolfo Gastalver

Co-Founder & CEO, Ploid AI Biotech

Co-Founder & CEO of Ploid AI. Computer and electrical engineer specialized in AI, with two Master's degrees and a PhD candidacy in electrical engineering. Former AI researcher at CSIC-IIIA, with startup and consulting experience at Ingelectus and BCG.

Ignacio Massone

CEO & Co-founder, Resistia

Former Big Pharma leader with a proven track record in business development and product launches. Currently Co-founder and CEO of Resistia, a deep-tech startup developing microbiome-derived therapies that restore the efficacy of existing antibiotics against resistant infections.

... Read More →

Wednesday September 30, 2026 15:15 - 16:30 CEST
4 Raúl Martín room

Startup pitch presentations

Audience English language
Track Finance & investment

11:30 CEST

12:15 CEST

15:15 CEST

10:15 CEST

11:30 CEST

15:15 CEST

Get help with the event